Vaccine development against systemic Acinetobacter baumannii infection

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

Bernard Arulanandam

Jieh-Juen Yu

Funded by

San Antonio Vaccine Development Center

Research Start Date

09/01/2015

Status

Active

Basic Research

Collaborative Project

Basic Research

Drug Discovery

Infectious Disease

Bioscience Research Panel